摘要
为了解原发性肝癌患者经肝动脉化疗栓塞（ＴＡＥ）治疗后免疫功能状态，我们检测２９例原发性肝癌患者血液可溶性白细胞介素２受体（ｓＩＬ２Ｒ）、辅助Ｔ淋巴细胞、抑制Ｔ淋巴细胞。发现原发性肝癌患者Ｔｈ细胞显著下降，Ｐ＜０．０５。ｓＩＬ２Ｒ、Ｔｓ细胞比健康对照组明显增高，Ｐ＜０．０５；ＴＡＥ治疗后原发性肝癌患者Ｔｈ细胞明显增高，Ｐ＜０．０５，ｓＩＬ２Ｒ、Ｔｓ细胞显著降低Ｐ＜０．０５。测定原发性肝癌患者血液中ｓＩＬ２Ｒ、Ｔｈ、Ｔｓ细胞对判断患者免疫功能状态、疗效、预后有一定的价值。
In order to know immune state in patients with primary hepatic cancer (PHC) after transcatheter hepatic artery embolization (TAE),we determined sera soluble interleukin 2 receptors and T lymphocytes subsets in 29 cases patients with liver cancer and 20cases health controls.The results showed that Th cells in patients with PHC are lower than that in control group, P <005;but sIL 2RTs cells in patients with liver cancer after TAE are highter significantly than that in control group, P <005
出处
《临床肝胆病杂志》
CAS
北大核心
1999年第1期48-50,共3页
Journal of Clinical Hepatology
